ObsEva to Host Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Business Update

Rhea-AI Summary

ObsEva SA (NASDAQ: OBSV; SIX: OBSN) announced a conference call on May 17, 2022, at 8:00 a.m. ET to discuss its financial results for the first quarter ending March 31, 2022, and to provide a business update. Participants can join via telephone or webcast, which will be archived on their website. ObsEva focuses on developing therapies for women’s health, including treatments for uterine fibroids, endometriosis, and preterm labor, establishing a late-stage clinical pipeline.

GENEVA, Switzerland – May 12, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that it plans to host a conference call on Tuesday, May 17, 2022, at 8:00 a.m. ET to discuss its financial results for the quarter ended March 31, 2022 and provide a business update.

Individuals may participate via telephone by dialling (877) 300-8521 (domestic) or +1 (412) 317-6026 (international) and using conference ID 10166576. The webcast can be accessed live here and will also be accessible under “Events Calendar” in the investors section of ObsEva’s website. The webcast will be archived on the company’s website for at least 30 days after the conference call.

About ObsEva
ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s health. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on new therapies for the treatment of uterine fibroids, endometriosis, and preterm labor. ObsEva is listed on the Nasdaq Global Select Market and is traded under the ticker symbol “OBSV” and on the SIX Swiss Exchange where it is traded under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com

For further information, please contact:

CEO Office contact
Shauna Dillon
shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact
Katja Bührer
katja.buhrer@obseva.com
+1 (917) 969-3438

 

Attachment

• Press Release in Pdf

FAQ

When will ObsEva announce its financial results for Q1 2022?

ObsEva will announce its financial results for Q1 2022 on May 17, 2022.

How can I join the ObsEva conference call?

You can join the ObsEva conference call by calling (877) 300-8521 for domestic or +1 (412) 317-6026 for international, using conference ID 10166576.

What is the focus of ObsEva's business?

ObsEva focuses on developing and commercializing novel therapies for women’s health, targeting uterine fibroids, endometriosis, and preterm labor.

Where can I access the conference call webcast for ObsEva?

The conference call webcast can be accessed live on the Globenewswire website and will be archived for at least 30 days on ObsEva's website.